Checkerspot closes $55 million financing to accelerate commercialization of biobased products

In California, biotechnology company Checkerspot announced the close of a $55 million Series C financing led by ArrowMark Partners, with participation from Cox Enterprises and other new and existing investors. The funding accelerates Checkerspot’s development and commercialization of high-performance, biobased alternatives for everyday products, the firm said. Checkerspot has previously launched a line of performance outdoor recreation products under its consumer brand, WNDR Alpine (Wonder Alpine). The firm said that WNDR Alpine animates and de-risks the adoption of biobased materials – developed with Checkerspot’s technology – that can be used across a wide range of industries. The firm noted that yhe latest proceeds accelerate Checkerspot’s expansion into new and adjacent markets including industrial applications, personal care, and food and nutrition.

More on the story.